A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

8.7K views

⸱

DOI:

10.3791/56515

⸱

March 30th, 2018

 ,  ,  ,  ,  ,  , 

In This Article

Summary

A simple method for obtaining NK and T cell clones from CAEBV patients was developed with high efficiency, a small amount of peripheral blood, and a low-dose of IL-2.

Abstract

A number of methods have been described to establish NK/T cell lines from patients with lymphoma or lymphoproliferative syndrome. These methods employed feeder cells, purified NK or T cells with as much as 10 mL of blood, or a high-dose of IL-2. This study presents a new method with a powerful and simple strategy to establish NK and T cell lines by culturing the peripheral blood mononuclear cells (PBMC) with the addition of recombinant human IL-2 (rhIL-2), and uses as little as 2 mL of whole blood. The cells can proliferate quickly in two weeks and be maintained for more than 3 months. With this method, 7 NK or T cell lines have been established with a high success rate. This method is simple, reliable, and applicable to establishing cell lines from more cases of CAEBV or NK/T cell lymphoma.

Introduction

Epstein-Barr virus (EBV) is ubiquitous and infects not only B cells, but also T and natural killer (NK) cells, which causes a number of EBV-associated NK/T lymphoproliferative diseases (LPD) and lymphoma/leukemia, such as EBV-associated hemophagocytic lymphohistiocytosis, hydroa vacciniforme-like lymphoma, extranodal NK/T-cell lymphoma, nasal type and aggressive NK cell leukemia1,2,3. Among these is severe chronic active EBV (SCAEBV) disease, which is incident mainly in East Asia, and which is now considered to be a LPD caused by clonal expansion of EBV-infected T or NK cells....

Access restricted. Please log in or start a trial to view this content.

Protocol

This study was approved by the Ethics Committee of the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and the protocol follows the institutional guidelines for human welfare.

NOTE: See Figure 1 for a schematic of the workflow.

1. Isolation of PBMC from CAEBV Patients

  1. Purify primary PBMC from 2 mL of whole blood of CAEBV patients by gradient (e.g., Ficoll-plaque) centrifugation following the manufacturer's instructions. Alternatively, thaw cryopreserved PBMC from liquid nitrogen with RPMI 1640 medium.
  2. Add 2 µL of t....

Access restricted. Please log in or start a trial to view this content.

Results

After 3 days culture during the establishment of cell lines, the polymorphic cells begin to appear (Figure 2). After 7 days, cells grow quickly, as both the number and viability of cells are increased at a high rate (Figure 3). Small clusters of cells are clearly visible after 10-14 days growing, when the cell concentration can exceed 3-6 × 106. In this period, cells should be expanded by division into two or three wel.......

Access restricted. Please log in or start a trial to view this content.

Discussion

In this protocol, a novel technique for establishing NK/T cell lines from whole blood of CAEBV patients has been developed. Compared with the existing methods, the major advantage of this method is its simplicity and its requirement of only a small volume of blood, while it exhibits a high success rate and good conditions of cell viability. Furthermore, NK/T cell lines can be established by culturing PBMC without determining the cell types the EBV latently infected in advance, as the determination would consume more bloo.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

D.Z., X.Z., and X.C. are co-inventors on pending patent applications covering potential uses of this method for establishing NK/T cell lines and the cell lines established in this study. D.Z., X.Z., and X.C. declare no competing financial interests in this work. The remaining authors declare they have no competing financial interests.

Acknowledgements

This work was supported by the Key Projects of Chinese Academy of Sciences (KFZD-SW-205), Strategic Biological Resources Technology Support System of Chinese Academy of Sciences (CZBZX-1 and ZSSB-004), and by Grants from National Science Foundation of China (81401640) and  Shanghai Natural Science Fund (14ZR1434800).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Hu HLA-DR FITCBD560944antibody for FACS
Hu CD4 FITCBD555346antibody for FACS
Hu/NHP CD8 PEBD557086antibody for FACS
Hu CD3 PEBD555340antibody for FACS
Hu CD16 FITC 3G8BD555406antibody for FACS
Hu/NHP CD56 PE MY31BD556647antibody for FACS
hu/CD19 PE-Cy7BD560728antibody for FACS
human IL-2Roche11147528001
human serumMRCCCC118-125
CO2 incubatorSANYO
CentrifugeTechcompCT6TCentrifugation
microscopeOLYMPUS CKX53CKX53
Automated Cell CounterCountstarIC 1000For cell counting
24 well cell culture clusterCorning Incorporated3524Polystyrene plates
25cm2 cell culture flaskNest707001Polystyrene
FBSGibco10270Component of cell medium
RPMI Medium 1640life22400089For cell medium
L-GlutamineAmresco374Component of cell medium
100 x streptomycin penicillin solution BioRoYeeBRY-2309BioRoYeeBRY-2309Component of cell medium
Ficoll paque plusGE Healthcare17-1440-03For in vitro isolation of lymphocyte
DMSOSigmaD2650For freezing cells
flow cytometerBDBD FACSAria II
soft wareBDBD FACSDiva soft wareFACS analysis

References

  1. Cohen, J. I. Epstein-Barr virus infection. N Engl J Med. 343 (7), 481-492 (2000).
  2. Cohen, J. I., Kimura, H., Nakamura, S., Ko, Y. H., Jaffe, E. S. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompro....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

NK T Cell LinesChronic Active EBVPeripheral Blood Mononuclear CellsRecombinant Human IL-2Flow Cytometry AnalysisGradient CentrifugationCell Culture MaintenancePhenotype DeterminationCell Proliferation MonitoringCryopreservation Technique